Cleared Traditional

K171560 - OTIS Optical Coherence Tomography System (FDA 510(k) Clearance)

Class II General & Plastic Surgery device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Aug 2017
Decision
87d
Days
Class 2
Risk

K171560 is an FDA 510(k) clearance for the OTIS Optical Coherence Tomography System. Classified as System, Imaging, Optical Coherence Tomography (oct) (product code NQQ), Class II - Special Controls.

Submitted by Perimeter Medical Imaging, Inc. (Toronto, CA). The FDA issued a Cleared decision on August 25, 2017 after a review of 87 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 892.1560 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

Submission Details

510(k) Number K171560 FDA.gov
FDA Decision Cleared Substantially Equivalent - Abbreviated 510(k) (SESU)
Date Received May 30, 2017
Decision Date August 25, 2017
Days to Decision 87 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Regulatory Context
Review time vs. panel average
45d faster than avg
Panel avg: 132d · This submission: 87d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code NQQ System, Imaging, Optical Coherence Tomography (oct)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1560
Definition This Device Uses Back-reflected Light To Create Two-dimensional Images Versus Back-reflected Sound Waves As Are Used In Ultrasound Imaging.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - NQQ System, Imaging, Optical Coherence Tomography (oct)

All 9
Devices cleared under the same product code (NQQ) and FDA review panel - the closest regulatory comparables to K171560.
LIA Console (542-7)
K251730 · Leadoptik, Inc. · Dec 2025
HyperVue™ Imaging System - Integrated
K253101 · Spectrawave, Inc. · Dec 2025
deepLive (OSP12 + DMS)
K252851 · Damae Medical · Oct 2025
HyperVue™ Software
K251198 · Spectrawave, Inc. · Jul 2025
OPUSWAVE Dual Sensor Imaging System
K250684 · Terumo Cardiovascular Systems Thi Plant · Jul 2025
OPXION Optical Skin Viewer (OPXSV1-01F)
K242924 · Opxion Technology, Inc. · Jun 2025